These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15102862)

  • 1. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB.
    Fujioka S; Schmidt C; Sclabas GM; Li Z; Pelicano H; Peng B; Yao A; Niu J; Zhang W; Evans DB; Abbruzzese JL; Huang P; Chiao PJ
    J Biol Chem; 2004 Jun; 279(26):27549-59. PubMed ID: 15102862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response.
    Li Z; Niu J; Uwagawa T; Peng B; Chiao PJ
    J Biol Chem; 2005 Apr; 280(17):16843-50. PubMed ID: 15671037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
    Tergaonkar V; Bottero V; Ikawa M; Li Q; Verma IM
    Mol Cell Biol; 2003 Nov; 23(22):8070-83. PubMed ID: 14585967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
    Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.
    Hideshima T; Ikeda H; Chauhan D; Okawa Y; Raje N; Podar K; Mitsiades C; Munshi NC; Richardson PG; Carrasco RD; Anderson KC
    Blood; 2009 Jul; 114(5):1046-52. PubMed ID: 19436050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy.
    Tergaonkar V; Pando M; Vafa O; Wahl G; Verma I
    Cancer Cell; 2002 Jun; 1(5):493-503. PubMed ID: 12124178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term incubation with proteasome inhibitors (PIs) induces IκBα degradation via the lysosomal pathway in an IκB kinase (IKK)-dependent and IKK-independent manner.
    Lee KH; Jeong J; Yoo CG
    J Biol Chem; 2013 Nov; 288(45):32777-32786. PubMed ID: 24085292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage.
    Aleyasin H; Cregan SP; Iyirhiaro G; O'Hare MJ; Callaghan SM; Slack RS; Park DS
    J Neurosci; 2004 Mar; 24(12):2963-73. PubMed ID: 15044535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.
    Fujioka S; Niu J; Schmidt C; Sclabas GM; Peng B; Uwagawa T; Li Z; Evans DB; Abbruzzese JL; Chiao PJ
    Mol Cell Biol; 2004 Sep; 24(17):7806-19. PubMed ID: 15314185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity.
    Jeong SJ; Radonovich M; Brady JN; Pise-Masison CA
    Blood; 2004 Sep; 104(5):1490-7. PubMed ID: 15155458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.
    Juvekar A; Manna S; Ramaswami S; Chang TP; Vu HY; Ghosh CC; Celiker MY; Vancurova I
    Mol Cancer Res; 2011 Feb; 9(2):183-94. PubMed ID: 21224428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
    Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
    Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis.
    Das A; Chendil D; Dey S; Mohiuddin M; Mohiuddin M; Milbrandt J; Rangnekar VM; Ahmed MM
    J Biol Chem; 2001 Feb; 276(5):3279-86. PubMed ID: 11035041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
    Sung B; Pandey MK; Aggarwal BB
    Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB activation.
    Jeong JB; Yang X; Clark R; Choi J; Baek SJ; Lee SH
    Carcinogenesis; 2013 Oct; 34(10):2350-60. PubMed ID: 23784084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.